<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565551</url>
  </required_header>
  <id_info>
    <org_study_id>RC2NS069409</org_study_id>
    <secondary_id>RC2NS069409</secondary_id>
    <nct_id>NCT01565551</nct_id>
  </id_info>
  <brief_title>Transforming Research and Clinical Knowledge in TBI Pilot</brief_title>
  <official_title>Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The global aim of this proposal is to test and refine Common Data Elements (CDEs),
      neuroimaging standards, and best practices for genetics and proteomics in Traumatic Brain
      Injury (TBI) studies. Testing and validating of TBI-CDEs will be performed in a multi-center
      prospective observational study with 3 TBI Centers (San Francisco General Hospital (SFGH),
      University of Pittsburgh Medical Center (UPMC), University Medical Center Brackenridge
      (UMCB)) and a TBI Rehabilitation Center (Mount Sinai Rehabilitation Center (MSMC)). The
      investigators will create and expand existing data repositories for patient demographics,
      neuroimaging, plasma biomarkers, genetics, and multivariate outcomes thereby providing
      researchers and clinicians with the infrastructure to establish multidisciplinary,
      multicenter research networks and improve clinical research in the TBI field.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Investigators aim for a 10-month data collection period for TBI patients across the
      spectrum from concussion to coma with a limited 3-month follow up and extensive 6-, 12-, and
      24-month follow ups. Patient enrollment will occur in three high-volume TBI Centers (SFGH,
      UPMC, UMCB) and a TBI Rehabilitation Center (MSMC). These Centers have a long track record of
      multi-center TBI research experience as well as existing infrastructure for rapid start-up
      and sustained enrollment. All patients admitted acutely with a history of external force
      injury to the head with a head CT performed in the emergency department are eligible for
      enrollment. Head CTs are performed according to the American College of Emergency Physicians
      (ACEP) and the Centers for Disease Control and Prevention (CDC) Guidelines for neuroimaging
      and decision making in TBI. These Guidelines are already in place at the participating
      Centers and are used to determine which patients will receive a non-contrast head CT scan as
      part of their initial evaluation. Patients will not be excluded based on age, race, gender,
      ethnicity, substance abuse, or prior psychiatric history to provide a population-based sample
      of of TBI subjects across the injury spectrum from concussion to coma.

      Study Components (Ref: NIH-NINDS TBI Common Data Elements):

        1. Clinical Care and Demographic Data Collection. Variables include: date and time of
           injury, mechanism of injury, acute laboratory values and vital signs, neurological
           evaluations, surgical interventions, hospital course, morbidity and mortality during
           acute care.

        2. Blood Draw for Proteomic and Genetic Marker Analyses. Blood samples will be drawn within
           24 hours of injury. Plasma will be spun and separated from whole blood. Both plasma and
           whole blood samples will be banked centrally under -80 degrees Celsius at the University
           of California, San Francisco (UCSF) DNA Bank.

        3. 3-Tesla (3T) Magnetic Resonance Imaging. A 3T Research MRI will be completed on a subset
           of patients able to return 1-2 weeks post-injury.

        4. 3-Month Follow Up. The Glasgow Outcome Scale - Extended (GOS-E) and neurological
           symptoms inventory will be administered to patients over the phone 3 months post-injury.

        5. 6-, 12-, and 24-Month Neurocognitive Assessment. Standardized measures from all
           designated CORE domains for outcome after TBI by TBI-CDEs, which include: global
           recovery, functional outcome, psychological impairment, post-traumatic stress disorder
           (PTSD), and quality of life, will be administered to the participant.

      The investigators anticipate that this project has the potential to substantially advance and
      revolutionize clinical research in TBI. Repositories for neuroimaging, proteomic, and genetic
      biomarkers will facilitate the evolving field of these emerging technologies in TBI.

      Recent Publications:

      Yue JK, Vassar MJ, Lingsma H, Cooper SR, Yuh EL, Mukherjee P, Puccio AM, Gordon W, Okonkwo
      DO, Valadka A, Schnyer DM, Maas A, Manley GT; TRACK-TBI Investigators. Transforming Research
      and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot: Multicenter
      Implementation of the Common Data Elements for Traumatic Brain Injury. J Neurotrauma. 2013
      Nov 15;30(22):1831-44.

      Dams-O'Connor K, Spielman L, Singh A, Gordon WA, Lingsma HF, Maas AI, Manley GT, Mukherjee P,
      Okonkwo DO, Puccio AM, Schnyer DM, Valadka AB, Yue JK, Yuh EL; TRACK-TBI Investigators. The
      Impact of Prior Traumatic Brain Injury on Health and Functioning: a TRACK-TBI Study. J
      Neurotrauma. 2013 Dec 15;30(24):2014-20.

      McMahon PJ, Hricik AJ, Yue JK, Puccio AM, Inoue T, Lingsma H, Beers SR, Gordon W, Valadka, A,
      Manley GT, Okonkwo DO; TRACK-TBI Investigators. Symptomatology and Functional Outcome in Mild
      Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study. J Neurotrauma. 2013 Oct
      31. [Epub ahead of print]

      Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL,
      Lingsma H, Maas A, Valadka A, Okonkwo DO, Manley GT; TRACK-TBI Investigators. Acute
      Biomarkers of Traumatic Brain Injury: Relationship Between Plasma Levels of Ubiquitin
      C-Terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP). J Neurotrauma.
      2013 Oct 9. [Epub ahead of print]

      Okonkwo DO, Yue JK, Puccio AM, Panczykowski D, Inoue T, McMahon PJ, Sorani MD, Yuh EL,
      Lingsma H, Maas A, Valadka A, Manley GT; TRACK-TBI Investigators. GFAP-BDP as an Acute
      Diagnostic Marker of Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study. J
      Neurotrauma. 2013 Sep 1;30(17):1490-7.

      Yuh EL, Mukherjee P, Lingsma HF, Yue JK, Ferguson AR, Gordon WA, Valadka AB, Schnyer DM,
      Okonkwo DO, Maas AI, Manley GT; TRACK-TBI Investigators. Magnetic Resonance Imaging Improves
      3-Month Outcome Prediction in Mild Traumatic Brain Injury. Ann Neurol. 2013 Feb;73(2):224-35.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glasgow Outcome Scale Extended (GOSE)</measure>
    <time_frame>6 Months Post-Injury</time_frame>
    <description>The GOSE provides and overall measure of disability based on information on cognition, independence, employability, and social/community participation collected via structured interview. Individuals are described by one of the eight outcome categories: Dead (1); Vegetative State (2); Lower Severe Disability (3); Upper Severe Disability (4); Lower Moderate Disability (5); Upper Moderate Disability (6); Lower Good Recovery (7) and Upper Good Recovery (8). Good Recovery is defined as a score of 7-8, Moderate Disability is defined by a score of 5-6 and Severe Disability is defined by a score of 3-4.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">650</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Early-Presenting TBI: Acute Sites</arm_group_label>
    <description>This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late-Presenting TBI: Rehabilitation Center</arm_group_label>
    <description>This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>N/A (Observational Study)</intervention_name>
    <description>No Interventions: Observational Study</description>
    <arm_group_label>Early-Presenting TBI: Acute Sites</arm_group_label>
    <arm_group_label>Late-Presenting TBI: Rehabilitation Center</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood for genetic analysis. Plasma for proteomic analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This is a population-based TBI study. All patients presenting to the acute sites with
        traumatic brain injury and receive a head CT scan as part of standard care within 24 hours
        of injury date and time are initially eligible. As most six-month Common Date Elements
        (CDE) outcome measures are normed and validated only in English, study participants must be
        English-speaking. There are no other restrictions to eligibility.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presentation to Emergency Department &lt; 24 hours post-injury

          -  Head CT scan for Traumatic Brain Injury (TBI) as part of regular care.

          -  English Speaking

        Exclusion Criteria:

          -  Presentation to Emergency Department &gt; 24 hours post-injury

          -  Custody or Incarceration

          -  5150 Psychiatric Hold

        Component-Specific Exclusion Criteria:

        MRI: Pregnant or may be pregnant; younger than 8 years old; those who have cardiac
        pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically
        implanted metal plates, screws or pins, cochlear implants, intrauterine devices (IUDs), or
        metal objects in their body, especially in the eye. Persons with a history of
        claustrophobia are excluded from this procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geoffrey T Manley, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco (San Francisco, CA)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David O Okonkwo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alex B Valadka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center, Brackenridge (Austin, TX)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wayne A Gordon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Rehabilitation Center (New York, NY)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Francisco General Hospital (SFGH)</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Rehabilitation Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center (UPMC)</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center, Brackenridge</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Finkelstein E, Corso P, Miller T. The Incidence and Economic Burden of Injuries in the United States. New York, NY: Oxford University Press; 2006.</citation>
  </reference>
  <reference>
    <citation>Foulkes AM, Eisenberg MH, Jane AJ. The Traumatic Coma Data Bank; design, methods and baseline characteristics. J. Neuroch. 75, S1-S15, 1991</citation>
  </reference>
  <reference>
    <citation>Jagoda AS, Bazarian JJ, Bruns JJ Jr, Cantrill SV, Gean AD, Howard PK, Ghajar J, Riggio S, Wright DW, Wears RL, Bakshy A, Burgess P, Wald MM, Whitson RR. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. J Emerg Nurs. 2009 Apr;35(2):e5-40. doi: 10.1016/j.jen.2008.12.010. Review.</citation>
    <PMID>19285163</PMID>
  </reference>
  <reference>
    <citation>Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008 Aug;7(8):728-41. doi: 10.1016/S1474-4422(08)70164-9. Review.</citation>
    <PMID>18635021</PMID>
  </reference>
  <reference>
    <citation>Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI. IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007 Feb;24(2):239-50.</citation>
    <PMID>17375988</PMID>
  </reference>
  <reference>
    <citation>Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992 Mar;9 Suppl 1:S287-92.</citation>
    <PMID>1588618</PMID>
  </reference>
  <reference>
    <citation>MRC CRASH Trial Collaborators, Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ. 2008 Feb 23;336(7641):425-9. doi: 10.1136/bmj.39461.643438.25. Epub 2008 Feb 12.</citation>
    <PMID>18270239</PMID>
  </reference>
  <reference>
    <citation>Murray GD, Teasdale GM, Braakman R, Cohadon F, Dearden M, Iannotti F, Karimi A, Lapierre F, Maas A, Ohman J, Persson L, Servadei F, Stocchetti N, Trojanowski T, Unterberg A. The European Brain Injury Consortium survey of head injuries. Acta Neurochir (Wien). 1999;141(3):223-36.</citation>
    <PMID>10214478</PMID>
  </reference>
  <reference>
    <citation>Ng J, Wahl M, Tong L, Lee H, Veeraraghavan S, Xu D, Zhao S, Kornak J, Meeker M, Ghajar J, Manley GT, Mukherjee P. 3T Diffusion Tensor Imaging of Mild Traumatic Brain Injury: A Prospective Longitudinal Study. Proc ISMRM 2009; 641.</citation>
  </reference>
  <reference>
    <citation>Niogi SN, Mukherjee P, Ghajar J, Johnson CE, Kolster R, Lee H, Suh M, Zimmerman RD, Manley GT, McCandliss BD. Structural dissociation of attentional control and memory in adults with and without mild traumatic brain injury. Brain. 2008 Dec;131(Pt 12):3209-21. doi: 10.1093/brain/awn247. Epub 2008 Oct 24.</citation>
    <PMID>18952679</PMID>
  </reference>
  <reference>
    <citation>Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT; Workshop Scientific Team and Advisory Panel Members. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008 Jul;25(7):719-38. doi: 10.1089/neu.2008.0586.</citation>
    <PMID>18627252</PMID>
  </reference>
  <reference>
    <citation>Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008 Aug 5;5(8):e165; discussion e165. doi: 10.1371/journal.pmed.0050165.</citation>
    <PMID>18684008</PMID>
  </reference>
  <reference>
    <citation>Rusnak M, Janciak I, Majdan M, Wilbacher I, Mauritz W; Australian Severe TBI Study Investigators. Severe traumatic brain injury in Austria VI: effects of guideline-based management. Wien Klin Wochenschr. 2007 Feb;119(1-2):64-71.</citation>
    <PMID>17318752</PMID>
  </reference>
  <reference>
    <citation>Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M, Gollub RL, Hua K, Zhang J, Jiang H, Dubey P, Blitz A, van Zijl P, Mori S. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage. 2007 Jul 1;36(3):630-44. Epub 2007 Mar 20.</citation>
    <PMID>17481925</PMID>
  </reference>
  <reference>
    <citation>Yuh EL, Gean AD, Manley GT, Callen AL, Wintermark M. Computer-aided assessment of head computed tomography (CT) studies in patients with suspected traumatic brain injury. J Neurotrauma. 2008 Oct;25(10):1163-72. doi: 10.1089/neu.2008.0590.</citation>
    <PMID>18986221</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2012</study_first_submitted>
  <study_first_submitted_qc>March 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <results_first_submitted>January 3, 2014</results_first_submitted>
  <results_first_submitted_qc>January 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 17, 2014</results_first_posted>
  <last_update_submitted>January 3, 2014</last_update_submitted>
  <last_update_submitted_qc>January 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>Common Data Elements</keyword>
  <keyword>Prognostic Models</keyword>
  <keyword>Neuroimaging</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Genetic Variants</keyword>
  <keyword>Concussion</keyword>
  <keyword>Psychological Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Early-Presenting TBI: Acute Sites</title>
          <description>This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
        <group group_id="P2">
          <title>Late-Presenting TBI: Rehabilitation Center</title>
          <description>This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="586"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Clinical/Demographics</title>
              <participants_list>
                <participants group_id="P1" count="586"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Biospecimens/Biomarkers</title>
              <participants_list>
                <participants group_id="P1" count="479"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Neuroimaging</title>
              <participants_list>
                <participants group_id="P1" count="233"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6-Month Outcomes</title>
              <participants_list>
                <participants group_id="P1" count="412"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="586"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early-Presenting TBI: Acute Sites</title>
          <description>This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
        <group group_id="B2">
          <title>Late-Presenting TBI: Rehabilitation Center</title>
          <description>This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="586"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="637"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.3" spread="18.5"/>
                    <measurement group_id="B2" value="49.9" spread="20.4"/>
                    <measurement group_id="B3" value="43.9" spread="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="167"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="419"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="471"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="495"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="528"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Glasgow Outcome Scale Extended (GOSE)</title>
        <description>The GOSE provides and overall measure of disability based on information on cognition, independence, employability, and social/community participation collected via structured interview. Individuals are described by one of the eight outcome categories: Dead (1); Vegetative State (2); Lower Severe Disability (3); Upper Severe Disability (4); Lower Moderate Disability (5); Upper Moderate Disability (6); Lower Good Recovery (7) and Upper Good Recovery (8). Good Recovery is defined as a score of 7-8, Moderate Disability is defined by a score of 5-6 and Severe Disability is defined by a score of 3-4.</description>
        <time_frame>6 Months Post-Injury</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early-Presenting TBI: Acute Sites</title>
            <description>This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).
N/A (Observational Study): No Interventions: Observational Study</description>
          </group>
          <group group_id="O2">
            <title>Late-Presenting TBI: Rehabilitation Center</title>
            <description>This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).
N/A (Observational Study): No Interventions: Observational Study</description>
          </group>
        </group_list>
        <measure>
          <title>Glasgow Outcome Scale Extended (GOSE)</title>
          <description>The GOSE provides and overall measure of disability based on information on cognition, independence, employability, and social/community participation collected via structured interview. Individuals are described by one of the eight outcome categories: Dead (1); Vegetative State (2); Lower Severe Disability (3); Upper Severe Disability (4); Lower Moderate Disability (5); Upper Moderate Disability (6); Lower Good Recovery (7) and Upper Good Recovery (8). Good Recovery is defined as a score of 7-8, Moderate Disability is defined by a score of 5-6 and Severe Disability is defined by a score of 3-4.</description>
          <units>Glasgow Outcome Scale Extended (GOSE)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="414"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="5" upper_limit="8"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 Months Post-Injury</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Early-Presenting TBI: Acute Sites</title>
          <description>This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
        <group group_id="E2">
          <title>Late-Presenting TBI: Rehabilitation Center</title>
          <description>This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).
N/A (Observational Study): No Interventions: Observational Study</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Enrolling patients representative of the TBI population created challenges for follow-up (e.g. homelessness, substance abuse); limited access to research MRI scanner; lack of validated outcome measures for non-English-speaking and pediatric patients.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Geoffrey Manley, MD, PhD</name_or_title>
      <organization>University of California, San Francisco</organization>
      <phone>415-206-8300</phone>
      <email>manleyg@neurosurg.ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

